Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key ...

In April 2024, Entera announced that the Journal of Bone and Mineral Research (JBMR) published EB613 placebo controlled Phase ...

OPK's growth is fueled by Rayaldee's success and promising pipeline progress. However, margin pressure and overdependence on its lead product are concerning.

In a report released today, Joe Feldman from Telsey Advisory maintained a Buy rating on Best Buy Co (BBY – Research Report), with a price ...

NextPlat Corp (NXPL) reports a 66% increase in recurring revenue airtime contracts and strategic expansions, despite facing profit margin pressures and non-recurring expenses.

Commerce provider, today announced the financial results for the fiscal year-ended December 31, 2024 which includes the consolidation of the operations of its e-Commerce Operations with ...